JAPhA Practice Innovations

Elsevier

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

JAPhA Practice Innovations is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 850 USD. Declared review time at DOAJ: 43 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2949-9690
Country
United States
Languages
english
Access
Open access
Declared publication charge
850 USD
Articles in DOAJ
49
Declared review time
43 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2025-01-08
Indexing
DOAJ
APC
850 USD
Declared review time (DOAJ)
43 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

49

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

43weeks

Works in OpenAlex

98

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

3

i10-index

0

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2026-04-27
Added to DOAJ
2025-01-08
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
93%
ORCID iDs in current deposits
94%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918900802606676
Classification4

Subjects (DOAJ)

Medicine: Pharmacy and materia medicaMedicine: Public aspects of medicine

LCC codes

RS1-441RA1-1270

Subject areas

  • Pharmacy and Medical Practices
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical Practices and Patient Outcomes
  • Medication Adherence and Compliance
  • Medication Adherence and Compliance
  • Pharmacy and Medical Practices
  • Pharmacy and Medical Practices
Show all subjects (75)
  • Interprofessional Education and Collaboration
  • Vaccine Coverage and Hesitancy
  • Diabetes Treatment and Management
  • Nursing Roles and Practices
  • Nursing Roles and Practices
  • Medication Adherence and Compliance
  • Interprofessional Education and Collaboration
  • Diabetes Management and Education
  • Opioid Use Disorder Treatment
  • Heart Failure Treatment and Management
  • Interprofessional Education and Collaboration
  • Heart Failure Treatment and Management
  • Antibiotic Use and Resistance
  • Substance Abuse Treatment and Outcomes
  • HIV/AIDS Research and Interventions
  • Antibiotic Use and Resistance
  • Substance Abuse Treatment and Outcomes
  • Health Policy Implementation Science
  • Antibiotic Use and Resistance
  • Diabetes Management and Research
  • Substance Abuse Treatment and Outcomes
  • Electronic Health Records Systems
  • Diabetes Treatment and Management
  • HIV, Drug Use, Sexual Risk
  • Pharmaceutical studies and practices
  • Electronic Health Records Systems
  • Patient Safety and Medication Errors
  • Health Policy Implementation Science
  • Health Sciences Research and Education
  • Pharmaceutical studies and practices
  • HIV, Drug Use, Sexual Risk
  • Pharmaceutical studies and practices
  • Atrial Fibrillation Management and Outcomes
  • Diabetes Treatment and Management
  • Health Sciences Research and Education
  • Electronic Health Records Systems
  • Health Policy Implementation Science
  • Patient Safety and Medication Errors
  • Dietetics, Nutrition, and Education
  • Atrial Fibrillation Management and Outcomes
  • HIV/AIDS Research and Interventions
  • Innovations in Medical Education
  • Diabetes Management and Research
  • Opioid Use Disorder Treatment
  • Diabetes Management and Education
  • Telemedicine and Telehealth Implementation
  • Primary Care and Health Outcomes
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical Economics and Policy
  • Primary Care and Health Outcomes
  • Vaccine Coverage and Hesitancy
  • Diabetes Management and Education
  • Opioid Use Disorder Treatment
  • Vaccine Coverage and Hesitancy
  • Diabetes Management and Research
  • Innovations in Medical Education
  • HIV/AIDS Research and Interventions
  • Health Systems, Economic Evaluations, Quality of Life
  • Atrial Fibrillation Management and Outcomes
  • Patient-Provider Communication in Healthcare
  • Health Promotion and Cardiovascular Prevention
  • Pharmacology and Obesity Treatment
  • Hospital Admissions and Outcomes
  • HIV, Drug Use, Sexual Risk
  • Innovations in Medical Education
  • Pharmaceutical Economics and Policy
  • Smoking Behavior and Cessation

Keywords (DOAJ)

  • pharmacy practice
  • public health promotion
  • medication optimization
  • pharmacotherapy
  • new technologies

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: